Plus Therapeutics, Inc. (Nasdaq: PSTV) specializes in targeted radiation treatments Rather than traditional radiation beams, Plus uses needle-sized applicators into brain fluid Focused on brain cancer which is difficult to […]
In an interview with Cheddar TV’s Kristen Scholer, IPO Edge Editor-in-Chief John Jannarone explains that many companies are prepared to go public in 2023 but a number of stars needs to align for successful deals. […]
In the wake of an unprecedented SPAC boom, investors and dealmakers face fresh challenges. While many companies fought short attacks after listing via SPAC, there is now scope for […]
The second annual Palm Beach CorpGov Forum will held on Thursday, February 9 (following a hurricane-related postponement from November), featuring a full day of panels and fireside chats followed by a cocktail […]
Direct Digital Holdings Co-Founder, Chairman and CEO Mark Walker Direct Digital Holdings, Inc. (Nasdaq: DRCT) completed IPO in February Specializes in connecting multicultural news and media platforms with advertisers Helps […]
Len Liptak, Co-founder & CEO By IPO Edge Editorial Staff IPO Edge: Can you give me a short description of what ProSomnus does? ProSomnus is a pioneer of precision intraoral […]
In the wake of an unprecedented SPAC boom, investors and dealmakers face fresh challenges. While many companies fought short attacks after listing via SPAC, there is now scope for more […]
IPO Edge and the Palm Beach Hedge Fund Association hosted a fireside chat with reAlpha to discuss the company’s business model and points of differentiation, competitive advantage, why fractionalized ownership is attractive for […]
IPO Edge and the Palm Beach Hedge Fund Association hosted a fireside chat with reAlpha to discuss the company’s business model and points of differentiation, competitive advantage, why fractionalized ownership is attractive for […]
In the wake of an unprecedented SPAC boom, investors and dealmakers face fresh challenges. While many companies fought short attacks after listing via SPAC, there is now scope for more […]
© Copyright 2025, IPO Edge